SMALLPOX
Clinical trials for SMALLPOX explained in plain language.
Never miss a new study
Get alerted when new SMALLPOX trials appear
Sign up with your email to follow new studies for SMALLPOX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mRNA mpox vaccine enters key trial in africa
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new mRNA vaccine (BNT166a) to see if it is safe and triggers a strong immune response against mpox (formerly monkeypox). About 310 healthy adults in African countries will receive either the vaccine or a placebo. The trial includes people who have never been ex…
Matched conditions: SMALLPOX
Phase: PHASE2 • Sponsor: BioNTech SE • Aim: ⭐️ VACCINE ⭐️
Last updated May 07, 2026 18:41 UTC
-
New poxvirus drug candidate enters first human safety trial
Knowledge-focused Recruiting nowThis early-stage study is testing an investigational drug called BSY001 in 76 healthy adults to see if it is safe and how the body processes it. Participants will receive either the drug or a placebo, and researchers will monitor side effects and drug levels in the blood. The goa…
Matched conditions: SMALLPOX
Phase: PHASE1 • Sponsor: China National Biotec Group Company Limited • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC